Sánchez-Morales Germán E, Osorio-Serrano Jorge L, Guerrero-Gómez Alan, Chan Carlos, Domínguez-Rosado Ismael
Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"; Mexico City, Mexico.
Cir Cir. 2023 Oct 2;92(4):451-455. doi: 10.24875/CIRU.22000379.
Pancreas is considered one of the organs most frequently affected by recurrence after nephrectomy secondary to renal cell carcinoma reporting an incidence of 20%, 85% of these occur within the first 3 years.
The objective of the study is to evaluate overall survival and disease-free survival in patients with renal cancer and pancreatic metastases who underwent surgical treatment.
A retrospective cross-sectional study of patients with histological diagnosis of renal cancer associated with pancreatic metastasis was performed and included those treated by pancreatoduodenectomy or distal pancreatectomy during the period 1987-2020.
14 patients with pancreatic metastasis were included. Two groups of patients were obtained: those who underwent pancreatic surgery for metastasis and those who did not undergo surgical procedure. According to the location of the metastasis, 71.4% corresponded to a single location and 28.6% to multiple locations. 57.1% underwent Whipple and 42.9% distal pancreatectomy. Survival after the surgical procedure was 1150 days versus 499 days in non-operated patients.
Pancreatic metastases due to RCC can be curable, improve morbidity, and increase disease-free survival with surgical treatment.
胰腺被认为是肾细胞癌肾切除术后最常发生复发的器官之一，复发率为20%，其中85%发生在头3年内。
本研究的目的是评估接受手术治疗的肾癌伴胰腺转移患者的总生存期和无病生存期。
对组织学诊断为肾癌伴胰腺转移的患者进行回顾性横断面研究，纳入1987年至2020年期间接受胰十二指肠切除术或远端胰腺切除术治疗的患者。
纳入14例胰腺转移患者。分为两组：接受胰腺转移手术的患者和未接受手术的患者。根据转移部位，71.4%为单一部位，28.6%为多个部位。57.1%接受了惠普尔手术，42.9%接受了远端胰腺切除术。手术后的生存期为1150天，而未手术患者为499天。
肾细胞癌引起的胰腺转移通过手术治疗可治愈，改善发病率，并提高无病生存期。
